COVID-19

Randall A. Oyer, MD, discusses rising cancer mortality during the coronavirus disease 2019 (COVID-19) pandemic and what that means for cancer care.

Pfizer and BioNTech, and Moderna have announced agreements to further supply vaccines against the coronavirus disease 2019 (COVID-19).

Telehealth has been crucial in expanding access to naloxone, a lifesaving drug used to reverse the effects of an opioid overdose.

According to AstraZeneca, the company is currently conducting a large trial in the US and in other countries around the world.

Deferred care can result in worse outcomes, advanced complications, or earlier death for many patients with cancer, heart disease, and other serious illnesses.

Pharmacy Times spoke with Jeremy Barnett, LMHC, CASAC & Expert at Help.org, about recommended plans and advice for those who are struggling with addiction during the holidays and the COVID-19 pandemic.

Pharmacy Times spoke with Jeremy Barnett, LMHC, CASAC & Expert at Help.org, about substance abuse dangers during COVID-19 and the holiday season.

Earlier this month, the Canadian government also exercised its option to increase its confirmed order commitment of mRNA-1273.

This agreement brings the total number to be delivered to the United States to 200 million.

In CNN's recent Sesame Street ABC's of COVID-19 town hall, Anthony Fauci, MD, answered questions addressing children’s concerns for Santa’s health during the COVID-19 pandemic.

A history of hypertension was found to increase the risk of acute kidney injury 5-fold, study results showed.

The kit will be shipped overnight to the customer’s home, where they can self-administer the test collection using a short nasal swab and send their sample back to Labcorp.

Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the process for managing the waiting period in the pharmacy following COVID-19 immunizations.

Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the process for immunizing staff at a hospital pharmacy with the COVID-19 vaccines.

Emphasizing the importance of the COVID-19 vaccine to younger generations and those with no underlying health conditions could significantly increase the overall rate of vaccination in the United States.

Pharmacy Times® interviewed Michael Flannery, PharmD, of the University of Rochester Medical Center, on the process that the hospital pharmacy has developed for vaccinations following the arrival of the Pfizer and Moderna COVID-19 vaccines.

The announcement came hours after the companies disclosed that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) had issued a positive opinion to authorize the vaccine.

Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the concerns he has regarding the COVID-19 vaccination process ahead.

The action allows for medicinal products to be authorized on a conditional basis for seriously debilitating or life-threatening diseases or for use in emergency situations in response to public health threats in the European Union.

Based on the pickup rates in the study, the investigators said kiosks could provide pharmacies significant annual savings because patients picked up an additional 400 prescriptions per year.

The ACIP advises the CDC on the populations and circumstances for which vaccines should be used.

Moderna’s COVID-19 vaccine (mRNA-1273) has been granted Emergency Use Authorization (EUA) by the FDA, making it the second vaccine to be issued an EUA for combating the virus.

Pharmacy Times® interviewed Sue Peschin of the COVID-19 Vaccine Education and Equity Project on the role of pharmacies in vaccinating the public with the COVID-19 vaccines.

Pharmacy Times® interviewed Sue Peschin, president and CEO of Alliance for Aging Research, on the work that the COVID-19 Vaccine Education and Equity Project is doing to engage diverse constituencies on the importance of the clinical trials process, regulatory review, and equitable access to COVID-19 vaccines.

Pharmacy Times® interviewed Sue Peschin, president and CEO of Alliance for Aging Research, on the work that the COVID-19 Vaccine Education and Equity Project is doing to support education about and equitable access to COVID-19 vaccines.

The additional doses bring the EC’s confirmed order commitment to 160 million doses, which will commence from the company’s dedicated European supply chain.

The COVID-19 pandemic has accelerated both acceptance and payment of novel care delivery models including telehealth.

Pharmacists can now play a larger role in increasing vaccination rates, while pharmacies can continue to be safe and convenient settings in which patients can receive vaccines.

If granted an EUA by the FDA, mRNA-1273 would become the second COVID-19 vaccine to receive the designation.

Pharmacists, physicians, and nurses have been among the first to receive COVID-19 vaccinations at health care facilities across the country.